loader image
Skip to main content
  • Economic Evaluation Basics
    0%

Focus Mode is ON. Click ‘X’ at right bottom to close it.

  • Previous
  • Glossary - Economic Evaluation Basics
    Introduction
    Enroll here
    Announcements
    Session 1: Introduction to Economic Evaluation
    Introduction to Economic Evaluation
    Session 2: Main Methods of Economic Evaluation
    Main Methods of Economic Evaluation
    Session 3: Framing an Economic Evaluation: Planning Phase
    Framing an Economic Evaluation: Planning Phase
    Session 4: Framing an Economic Evaluation: Analysis-Advocacy
    Framing an Economic Evaluation: Analysis-Advocacy
    Session 5: Cost-Effectiveness Case Study
    Cost-Effectiveness Case Study
    Glossary
    Glossary - Economic Evaluation Basics
    Final Exam
    Final Exam
    Course and Self Evaluation & Certificate
    Course Feedback
    Reference
    Reference
  • Next
  • Categories
    • All categories
    • Global Health eLearning Center
  • Home
  • Calendar
  • Account Info
  • Courses
  • Programs
  • Help
  • More
    About Us The Frank Foundation For Instructors
You are currently using guest access
Log in
Categories Collapse Expand
  • All categories
  • Global Health eLearning Center
Home Calendar Account Info Courses Programs Help More Collapse Expand
About Us The Frank Foundation For Instructors
Expand all Collapse all
Course Menu
  1. EEB
  2. Glossary
  3. Glossary - Economic Evaluation Basics

Glossary - Economic Evaluation Basics

Back

WHO criteria for cost-effectiveness

The WHO criteria were designed to be used with disability adjusted life years.

The discounted cost per life year gained for adolescents and adults is US$334 and US$613, respectively. To calculate the number of life years gained, the study authors multiplied the discounted HIV infection averted at different ages by the life expectancy at that age group less the years of survival that would have in any case occurred with HIV and treatment availability (8 years plus 14 years = 22 years).

According to the WHO, the per-capita GDP, adjusted for the purchasing power parity of the country, can be used for setting thresholds for cost-effectiveness. Thus, interventions for which the additional cost incurred to gain one quality-adjusted life year is less than the country’s per-capita GDP are considered as very cost-effective.

Considering that GDP per capita in Rwanda (based on 2007 estimates) is US$355, male circumcision (MC) for adolescents is slightly less than one GDP/per capita/life year gained and therefore highly cost-effective, while MC for adults is less than two GDP/per capita/life year gained and therefore potentially cost-effective.

 

» Glossary - Economic Evaluation Basics

Prev Section
Next Section
Contact site support
You are currently using guest access (Log in)
Get the mobile app
ghel
  • Privacy Policy
  • Terms of Use

Copyright © 2025 NextGenU.org / All Rights Reserved
Registered 501(c)(3). EIN: 23-2571610